View Older Stories

Jan 31, 2026 10:00AM This is one of the most 'underrated and under-the-radar biotech' stocks: Jefferies

Jan 20, 2026 02:33PM Ardelyx stock soars on report of potential Zydus Life acquisition

Jan 9, 2026 03:20AM Ardelyx, Inc (ARDX) PT Raised to $17 at BTIG

Jan 8, 2026 04:33PM Piper Sandler Upgrades Ardelyx, Inc (ARDX) to Overweight

Jan 8, 2026 12:41PM Ardelyx, Inc (ARDX) PT Raised to $19 at Raymond James, 'Guides FY29 a LOT Higher; IP Runway Extended'

Jan 8, 2026 09:49AM Ardelyx reports $378 million in 2025 revenue, projects growth

Jan 2, 2026 11:58AM Raymond James Reiterates Strong Buy Rating on Ardelyx, Inc (ARDX) Following Price Hikes

Dec 12, 2025 05:08AM Ardelyx, Inc (ARDX) PT Raised to $16 at Raymond James

Nov 25, 2025 05:08AM Ardelyx, Inc (ARDX) PT Raised to $15 at Raymond James

Nov 7, 2025 04:05PM Ardelyx presents real-world data on XPHOZAH at kidney conference

Oct 31, 2025 07:23AM Ardelyx, Inc (ARDX) PT Raised to $11 at Citi

Oct 30, 2025 04:52PM Ardelyx (ARDX) Tops Q3 EPS by 6c

Oct 28, 2025 08:02AM Ardelyx presents IBSRELA data at gastroenterology meeting

Oct 22, 2025 06:47AM Cantor Fitzgerald Reiterates Ardelyx, Inc (ARDX) at Overweight on Expected Ibsrela Upside

Sep 26, 2025 01:06PM Raymond James Reiterates Strong Buy Rating on Ardelyx, Inc (ARDX), PT $14

Aug 5, 2025 04:42PM Citi Opens 90d Upside Catalyst Call on Ardelyx (ARDX)

Aug 5, 2025 05:23AM Ardelyx, Inc (ARDX) PT Raised to $12 at Raymond James

Aug 4, 2025 04:09PM Ardelyx names new medical officer, technical operations chief

Aug 4, 2025 04:03PM Ardelyx (ARDX) Tops Q2 EPS by 5c

Jul 7, 2025 07:14AM Cantor Fitzgerald Reiterates Overweight Rating on Ardelyx, Inc (ARDX)

Jun 18, 2025 06:41AM H.C. Wainwright Assumes Ardelyx, Inc (ARDX) at Buy

Jun 2, 2025 04:05PM Ardelyx (ARDX) appoints new CBO and CHRO

May 6, 2025 08:02AM Ardelyx (ARDX) Presents Data Supporting IBSRELA

May 2, 2025 06:09AM Raymond James Downgrades Ardelyx, Inc (ARDX) to Outperform

May 1, 2025 04:02PM Ardelyx (ARDX) Misses Q1 EPS by 6c

Apr 10, 2025 04:03PM Ardelyx (ARDX): Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH to be Presented

Mar 31, 2025 04:04PM Ardelyx (ARDX) to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings

Mar 13, 2025 08:03AM Ardelyx (ARDX) Announces the First Recipients of Derek Forfang Patient Advocate Award

Mar 12, 2025 09:30AM Piper Sandler on Ardelyx, Inc (ARDX): 'Xphozah Uncertainty Continues to Leave Us Neutral Rated'

Mar 7, 2025 07:07AM Scotiabank Starts Ardelyx, Inc (ARDX) at Sector Outperform

Mar 4, 2025 06:59AM BTIG Starts Ardelyx, Inc (ARDX) at Buy

Feb 26, 2025 07:02AM Ardelyx (ARDX) Announces Tenapanor Approved in China for Hyperphosphatemia

Feb 21, 2025 06:48AM H.C. Wainwright Reiterates Neutral Rating on Ardelyx, Inc (ARDX)

Feb 20, 2025 07:41AM Ardelyx (ARDX) Tops Q4 EPS by 1c

Jan 13, 2025 08:17AM Ardelyx (ARDX) Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities

Nov 20, 2024 06:04AM Jefferies Reiterates Buy Rating on Ardelyx, Inc (ARDX)

Nov 11, 2024 06:21AM H.C. Wainwright Downgrades Ardelyx, Inc (ARDX) to Neutral

Nov 8, 2024 12:34PM Ardelyx (ARDX) Responds to District Court Decision Granting Motion to Dismiss

Nov 1, 2024 03:03PM Ardelyx (ARDX) call put ratio 16.1 calls to 1 put with focus on November 5 calls and January 9 calls as share price up 3.9%

Oct 31, 2024 04:04PM Ardelyx (ARDX) Tops Q3 EPS by 5c

Oct 24, 2024 04:06PM Ardelyx (ARDX) Reports Additional Data Supporting First-In-Class XPHOZAH

Oct 22, 2024 04:06PM Ardelyx (ARDX) Announces Launch of Gut Matters

Oct 9, 2024 08:05AM Ardelyx (ARDX) Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology

Oct 3, 2024 06:07AM Piper Sandler Reiterates Neutral Rating on Ardelyx, Inc (ARDX)

Aug 8, 2024 08:01AM Ardelyx (ARDX) Appoints Eric Foster as Chief Commercial Officer

Aug 5, 2024 06:57AM Ardelyx, Inc (ARDX) PT Raised to $11 at H.C. Wainwright

Aug 1, 2024 04:02PM Ardelyx (ARDX) Tops Q2 EPS by 4c

Jul 19, 2024 09:59AM H.C. Wainwright Reiterates Buy Rating on Ardelyx, Inc (ARDX)

Jul 5, 2024 06:34AM Ardelyx, Inc (ARDX) PT Lowered to $10 at H.C. Wainwright

Jul 3, 2024 07:06AM Ardelyx, Inc (ARDX) PT Lowered to $10 at Citi

View Older Stories